Moncef Slaoui (Alex Brandon/AP Images)
March 4, 2022 11:03 AM ESTUpdated March 7, 07:40 AM
People
Coronavirus

For­mer Warp Speed chief agrees to pay GSK back $3.9M fol­low­ing sex­u­al ha­rass­ment

Zachary Brennan

Senior Editor

Glax­o­SmithK­line’s long­time R&D chief Mon­cef Slaoui agreed to pay $3.86 mil­lion to his for­mer com­pa­ny as part of claw­back pro­vi­sions the com­pa­ny un­der­took to re­coup …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times